SEOUL, KOREA, November 22, 2022 /24-7PressRelease/ -- After 18 years in the industry as a global leading company, Live Cell Instrument (LCI) aims to be a global bio instrument specialized in bio-technology for live cell imaging systems and bio-consumables. The LCI's mission is to provide the most advanced technology and services to the bioscience industry and provide opportunities for potential bio-companies.
LCI began its career in 2004 when it was established in Korea to offer a live-cell system. Since then, LCI has earned a reputation across the country. Today, LCI continues to innovate and create new ventures to build innovative live cell systems.
In 2005, they registered and commercialized imaging chambers for microscopes. This Magnetic Imaging Chamber is designed to support a variety of imaging experiments. LCI constantly develops a platform for live cell imaging. The team developed an anti-vibration platform in 2008, which can help protect sensitive instruments from vibration and noise. In 2013, the team also established a research institute.
LEARN MORE - https://lcibio.com/products/live-cell-incubating-system-2-2/
By applying new innovative technologies, LCI launched Advanced Tissue clearing & Immunostaining devices in 2015, which could assist in the development and commercialization of tools that enable 3D investigation of a tissue's molecular and structural information via rapid clearing and immunostaining.
Following the success of Advanced Tissue clearing & Immunostaining, they advertised 4 products between 2018 to 2019 which include; Exosome separation Driving Device and Disc (Labspinner ODM) that specialized in extracellular vesicle(exosome) base. CTC liquid biopsy Driving Device and Disc (Clinomics ODM) specialized in Circulating Tumor Cell(CTC) base. Automated RNA/DNA Extraction System (Genolution ODM) conducts manufacturing/service business such as IVD medical instruments focused on molecular diagnostics, RNAi-related products, and services. Integrated platform for mechanically conditioned cells and tissue (Curibio ODM). For LCI, the progress never ends. They released the incubator system T and the Image ExFlourer in 2020.
To help improve national health through expert services in the area of medical devices, LCI launched a medical device division in 2021. They sell and supply sustainable categories of medical devices in dermatology, general practitioners, and internal medicine, including diagnostic equipment, laser management, treatment equipment, and consumable supplies.
SEE GLOBAL PARTNERSHIP - https://lcibio.com/company/research-partners/
Today, LCI continues to innovate and create new ventures to build innovative live cell systems.
Press release service and press release distribution provided by http://www.24-7pressrelease.com